Goldman Sachs’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01B | Buy |
2,136,072
+363,729
| +21% | +$183M | 0.12% | 166 |
|
|
2025
Q4 | $827M | Sell |
1,772,343
-39,869
| -2% | -$18.5M | 0.1% | 171 |
|
|
2025
Q3 | $772M | Buy |
1,812,212
+165,591
| +10% | +$64.2M | 0.09% | 192 |
|
|
2025
Q2 | $631M | Sell |
1,646,621
-62,638
| -4% | -$22.6M | 0.09% | 219 |
|
|
2025
Q1 | $591M | Buy |
1,709,259
+489,836
| +40% | +$158M | 0.1% | 202 |
|
|
2024
Q4 | $366M | Buy |
1,219,423
+80,536
| +7% | +$28.1M | 0.06% | 308 |
|
|
2024
Q3 | $463M | Sell |
1,138,887
-416,499
| -27% | -$152M | 0.07% | 254 |
|
|
2024
Q2 | $500M | Buy |
1,555,386
+419,606
| +37% | +$136M | 0.08% | 224 |
|
|
2024
Q1 | $379M | Sell |
1,135,780
-34,217
| -3% | -$10.5M | 0.07% | 299 |
|
|
2023
Q4 | $317M | Sell |
1,169,997
-100,165
| -8% | -$24.8M | 0.06% | 338 |
|
|
2023
Q3 | $312M | Sell |
1,270,162
-74,658
| -6% | -$20.4M | 0.07% | 277 |
|
|
2023
Q2 | $408M | Sell |
1,344,820
-41,029
| -3% | -$11.4M | 0.09% | 209 |
|
|
2023
Q1 | $365M | Buy |
1,385,849
+104,544
| +8% | +$26.6M | 0.08% | 235 |
|
|
2022
Q4 | $307M | Buy |
1,281,305
+143,987
| +13% | +$32.2M | 0.08% | 274 |
|
|
2022
Q3 | $209M | Sell |
1,137,318
-462,633
| -29% | -$92.2M | 0.05% | 372 |
|
|
2022
Q2 | $269M | Sell |
1,599,951
-739,173
| -32% | -$159M | 0.07% | 292 |
|
|
2022
Q1 | $586M | Buy |
2,339,124
+16,974
| +0.7% | +$4.26M | 0.12% | 138 |
|
|
2021
Q4 | $597M | Sell |
2,322,150
-45,752
| -2% | -$11.2M | 0.12% | 152 |
|
|
2021
Q3 | $575M | Sell |
2,367,902
-302,976
| -11% | -$74.1M | 0.12% | 149 |
|
|
2021
Q2 | $552M | Buy |
2,670,878
+11,903
| +0.4% | +$2.43M | 0.12% | 144 |
|
|
2021
Q1 | $501M | Buy |
2,658,975
+280,311
| +12% | +$49.4M | 0.13% | 150 |
|
|
2020
Q4 | $391M | Sell |
2,378,664
-785,607
| -25% | -$115M | 0.1% | 183 |
|
|
2020
Q3 | $395M | Buy |
3,164,271
+1,803,879
| +133% | +$223M | 0.11% | 159 |
|
|
2020
Q2 | $132M | Sell |
1,360,392
-436,713
| -24% | -$45.4M | 0.04% | 452 |
|
|
2020
Q1 | $161M | Sell |
1,797,105
-1,502,594
| -46% | -$195M | 0.06% | 329 |
|
|
2019
Q4 | $488M | Buy |
3,299,699
+524,907
| +19% | +$70.5M | 0.12% | 158 |
|
|
2019
Q3 | $334M | Buy |
2,774,792
+260,283
| +10% | +$33.6M | 0.1% | 201 |
|
|
2019
Q2 | $340M | Sell |
2,514,509
-700,888
| -22% | -$88.6M | 0.1% | 198 |
|
|
2019
Q1 | $419M | Buy |
3,215,397
+187,686
| +6% | +$25.2M | 0.13% | 140 |
|
|
2018
Q4 | $377M | Buy |
3,027,711
+1,248,520
| +70% | +$168M | 0.12% | 144 |
|
|
2018
Q3 | $248M | Sell |
1,779,191
-601,723
| -25% | -$74.9M | 0.06% | 328 |
|
|
2018
Q2 | $244M | Buy |
2,380,914
+677,181
| +40% | +$68.5M | 0.07% | 313 |
|
|
2018
Q1 | $165M | Buy |
1,703,733
+62,178
| +4% | +$6.03M | 0.04% | 511 |
|
|
2017
Q4 | $144M | Buy |
1,641,555
+49,383
| +3% | +$3.97M | 0.03% | 605 |
|
|
2017
Q3 | $127M | Buy |
1,592,172
+51,348
| +3% | +$4.13M | 0.03% | 669 |
|
|
2017
Q2 | $134M | Buy |
1,540,824
+31,571
| +2% | +$2.67M | 0.03% | 593 |
|
|
2017
Q1 | $134M | Buy |
1,509,253
+316,616
| +27% | +$26.4M | 0.04% | 573 |
|
|
2016
Q4 | $88.3M | Buy |
1,192,637
+280,800
| +31% | +$21M | 0.03% | 862 |
|
|
2016
Q3 | $69M | Sell |
911,837
-57,121
| -6% | -$4.37M | 0.02% | 972 |
|
|
2016
Q2 | $74.6M | Sell |
968,958
-41,794
| -4% | -$3.3M | 0.02% | 843 |
|
|
2016
Q1 | $78.9M | Buy |
1,010,752
+342,049
| +51% | +$23.9M | 0.03% | 796 |
|
|
2015
Q4 | $45.2M | Sell |
668,703
-659,411
| -50% | -$46M | 0.01% | 1204 |
|
|
2015
Q3 | $103M | Sell |
1,328,114
-107,641
| -7% | -$9.53M | 0.03% | 604 |
|
|
2015
Q2 | $130M | Sell |
1,435,755
-1,342,296
| -48% | -$108M | 0.04% | 518 |
|
|
2015
Q1 | $209M | Buy |
2,778,051
+1,471,176
| +113% | +$106M | 0.07% | 343 |
|
|
2014
Q4 | $95.9M | Buy |
1,306,875
+565,508
| +76% | +$39.7M | 0.03% | 694 |
|
|
2014
Q3 | $52.3M | Buy |
741,367
+209,202
| +39% | +$13.8M | 0.02% | 1033 |
|
|
2014
Q2 | $30M | Sell |
532,165
-108,766
| -17% | -$5.74M | 0.01% | 1472 |
|
|
2014
Q1 | $33.6M | Sell |
640,931
-344,812
| -35% | -$17.2M | 0.01% | 1344 |
|
|
2013
Q4 | $47M | Sell |
985,743
-804,891
| -45% | -$37.2M | 0.02% | 1087 |
|
|
2013
Q3 | $76.5M | Sell |
1,790,634
-521,045
| -23% | -$20.4M | 0.03% | 709 |
|
|
2013
Q2 | $83.4M | Buy |
+2,311,679
| New | +$89.4M | 0.03% | 623 |
|
Other funds holding HCA
VCM
VPM
Goldman Sachs's HCA Position: Q1 2026 in Review
Goldman Sachs increased its HCA Healthcare (HCA) stake by 21% in Q1 2026, buying an estimated $183M and bringing the position to 2,136,072 shares worth $1.01B. The position accounts for 0.12% of the portfolio, ranked #166.
Goldman Sachs first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Goldman Sachs held 2,136,072 shares of HCA Healthcare worth $1.01B as of Q1 2026.
- Goldman Sachs bought 363,729 HCA Healthcare shares in Q1 2026, an estimated $183M.
- HCA Healthcare made up 0.12% of Goldman Sachs's portfolio in Q1 2026, its #166 holding.
- Goldman Sachs first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.